I guess I did not communicate too effectively....I believe Kevetrin will be the indication that will make CTIX a household name at some point, but I was simply pointing out that in two or three months we will have results from P that could add to the support of Menon's genius. I believe the results of the K Phase I are stellar and consistent with the preclinical data (as noted in Leo's most recent PR). However, confirmation through Phase II with dosing somewhat optimized will really set the stage. A lot of interesting news coming up.
